These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9436668)

  • 1. Pharmacodynamics and pharmacokinetics after repeated subcutaneous administration of three gonadotrophin preparations.
    Duijkers IJ; Klipping C; Mulders TM; Out HJ; Coelingh Bennink HJ; Vemer HM
    Hum Reprod; 1997 Nov; 12(11):2379-84. PubMed ID: 9436668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioequivalence study of two urinary follicle stimulating hormone preparations: Follegon and Metrodin.
    Out HJ; Schnabel PG; Rombout F; Geurts TB; Bosschaert MA; Coelingh Bennink HJ
    Hum Reprod; 1996 Jan; 11(1):61-3. PubMed ID: 8671157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins.
    Huisman JA; Paulussen RJ; Geurts TB; Odink J; Rekers H
    Hum Reprod; 1997 Jan; 12(1):34-8. PubMed ID: 9043898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Pharmacodynamics of Follicle-Stimulating Hormone in Healthy Women Receiving Single and Multiple Doses of Highly Purified Human Menotrophin and Urofollitrophin.
    Di Stefano AF; Rusca A; Radicioni MM; Loprete L; Binelli D; Caccia G; Cometti B
    Clin Drug Investig; 2016 Dec; 36(12):1031-1044. PubMed ID: 27638053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of two human menopausal gonadotrophin preparations after single intravenous administration during pituitary suppression.
    Duijkers IJ; Beerens MC; Coelingh Bennink HJ; Huisman JA; Rombout F; Vemer HM
    Hum Reprod; 1995 Jun; 10(6):1367-72. PubMed ID: 7593498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization.
    Devroey P; Tjandraprawira K; Mannaerts B; Coelingh Bennink H; Smitz J; Bonduelle M; De Brabanter A; Van Steirteghem AC
    Hum Reprod; 1995 Feb; 10(2):332-7. PubMed ID: 7769058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone.
    Messinis IE; Milingos S; Zikopoulos K; Hasiotis G; Seferiadis K; Lolis D
    Hum Reprod; 1998 Sep; 13(9):2415-20. PubMed ID: 9806260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose proportionality study of subcutaneously and intramuscularly administered recombinant human follicle-stimulating hormone (Follistim*/Puregon) in healthy female volunteers.
    Voortman G; Mannaerts BM; Huisman JA
    Fertil Steril; 2000 Jun; 73(6):1187-93. PubMed ID: 10856481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity.
    Fleming R; Chung CC; Yates RW; Coutts JR
    Hum Reprod; 1996 Sep; 11(9):1854-8. PubMed ID: 8921053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular fluid hormone concentrations after ovarian stimulation using gonadotropin preparations with different FSH/LH ratios. I. Comparison of an FSH-dominant and a purified FSH preparation.
    Duijkers IJ; Willemsen WN; Hollanders HM; Hamilton CJ; Thomas CM; Vemer HM
    Int J Fertil Womens Med; 1997; 42(5):306-10. PubMed ID: 9406836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F; Scarinci E; Palla C; Romani F; Familiari A; Tropea A; Leoncini E; Lanzone A; Apa R
    Hum Reprod; 2015 Jan; 30(1):179-85. PubMed ID: 25398971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization.
    Balasch J; Fábregues F; Creus M; Moreno V; Puerto B; Peñarrubia J; Carmona F; Vanrell JA
    Hum Reprod; 1996 Nov; 11(11):2400-4. PubMed ID: 8981119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability in the immunoreactive and bioactive follicle stimulating hormone content of human urinary menopausal gonadotrophin preparations.
    Rodgers M; McLoughlin JD; Lambert A; Robertson WR; Mitchell R
    Hum Reprod; 1995 Aug; 10(8):1982-6. PubMed ID: 8567826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsatile subcutaneous versus bolus intramuscular gonadotrophin administration after pituitary suppression with a long-acting gonadotrophin-releasing hormone analogue: a controlled prospective study.
    De Geyter C; De Geyter M; Simoni M; Castro E; Bals-Pratsch M; Nieschlag E; Schneider HP
    Hum Reprod; 1994 Jun; 9(6):1070-6. PubMed ID: 7962378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-pharmacological studies on human menopausal gonadotrophin.
    Diczfalusy E; Harlin J
    Hum Reprod; 1988 Jan; 3(1):21-7. PubMed ID: 3127421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaco-dynamics of human menopausal gonadotrophin (HMG) and follicle-stimulating hormone (FSH). The importance of the FSH concentration in initiating follicular growth in polycystic ovary-like disease.
    van Weissenbruch MM; Schoemaker HC; Drexhage HA; Schoemaker J
    Hum Reprod; 1993 Jun; 8(6):813-21. PubMed ID: 8345068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers.
    le Cotonnec JY; Porchet HC; Beltrami V; Howles C
    Hum Reprod; 1993 Oct; 8(10):1604-11. PubMed ID: 8300814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.